We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Genetic Tests Could Indicate Personality Disorder

By HospiMedica staff writers
Posted on 20 Mar 2007
Genetic tests using blood samples are already used to diagnose some diseases and even personalize treatment. More...
It is possible to develop similar tests that reveal a person's potential to become dependent on nicotine or marijuana or have an antisocial personality disorder.
These tests would not dictate who would become substance dependent or have behavioral problems, as genes do not function in isolation, but are influenced by other genes and environmental factors. In a recent study, the researchers found certain differences in the genes of people with a history of smoking compared to those without such a history. In all, 579 genes were more expressed and 584 genes were less expressed in people who had smoked.
The technique used to analyze blood is called transcriptional profiling, said Anup Madan, UI adjunct assistant professor of neurosurgery and an assistant professor at the Institute of Systems Biology in Seattle (WA, USA). Transcription profiling involves looking at all the genes--nearly 30,000 of them--at one time. We label all the expressed genes by fluorescent tags, and changes in fluorescence intensity are used to identify differential gene expression.
The study was reported by University of Iowa (UI; Iowa City, IA, USA) scientists in the March 6, 2007, online edition of the American Journal of Molecular genetics. Our study suggests that analyzing the expression of genes in blood could indicate whether a person is susceptible to having a behavioral disorder. Having a particular gene expression change does not by itself predict that a person will act a certain way. However, it can indicate who might have a greater biological basis for engaging in behaviors such as smoking and alcohol or marijuana use, said the study's lead author Robert Philibert, M.D., Ph.D., professor of psychiatry in the UI Roy J. and Lucille A. Carver College of Medicine. What matters most is not whether you have a particular gene but whether the gene is expressed, and what other environmental factors may be at play. Genetic variation in and of itself is not deterministic, he added.
Our study suggests that analyzing the expression of genes in blood could indicate whether a person is susceptible to having a behavioral disorder. Having a particular gene expression change does not by itself predict that a person will act a certain way. However, it can indicate who might have a greater biologic basis for engaging in behaviors such as smoking and alcohol or marijuana use, Professor Philibert said.


Related Links:
Institute of Systems Biology in Seattle
University of Iowa

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.